Clinical Trial Update: Crossover Study of CNV1014802 in Subjects With Neuropathic Pain From Lumbosacral Radiculopathy [Phase 2]

View source ↗

Summary

Phase 2 crossover trial of CNV1014802 for neuropathic pain due to lumbosacral radiculopathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lumbosacral Radiculopathy
• Neuropathic Pain

Drugs mentioned

• CNV1014802

Snippet

Sponsor: Biogen | Conditions: Lumbosacral Radiculopathy | Phase 2 | Status: COMPLETED